ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,4,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2,3,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
3,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
5,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
7,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
9,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
9,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
12,1,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
12,2,Aortic valve incompetence,Aortic valvular disorders,Cardiac valve disorders,Card,N
12,3,Aortic valve thickening,Aortic valvular disorders,Cardiac valve disorders,Card,N
12,4,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
12,5,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
12,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
13,1,Alanine aminotransferase normal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
